103 related articles for article (PubMed ID: 3263191)
21. Flow cytometric analysis of low grade B-cell non-Hodgkin's lymphoma: correlation between histology, immunophenotyping and cell cycle analysis.
Lackowska B; Wasilewska A; Gruchała A; Ryś J; Szklarski W; Niezabitowski A
Pol J Pathol; 1994; 45(4):263-9. PubMed ID: 7697327
[TBL] [Abstract][Full Text] [Related]
22. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma.
Laane E; Tani E; Björklund E; Elmberger G; Everaus H; Skoog L; Porwit-MacDonald A
Cytometry B Clin Cytom; 2005 Mar; 64(1):34-42. PubMed ID: 15669024
[TBL] [Abstract][Full Text] [Related]
23. Equilibrium binding of DAPI and 7-aminoactinomycin D to chromatin of cultured cells.
Rundquist I
Cytometry; 1993; 14(6):610-7. PubMed ID: 8404367
[TBL] [Abstract][Full Text] [Related]
24. DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.
Teske E; Rutteman GR; Kuipers-Dijkshoorn NJ; van Dierendonck JH; van Heerde P; Cornelisse CJ
Exp Hematol; 1993 Apr; 21(4):579-84. PubMed ID: 8462667
[TBL] [Abstract][Full Text] [Related]
25. Cell- and stage-specific chromatin structure across the Complement receptor 2 (CR2/CD21) promoter coincide with CBF1 and C/EBP-beta binding in B cells.
Cruickshank MN; Fenwick E; Karimi M; Abraham LJ; Ulgiati D
Mol Immunol; 2009 Aug; 46(13):2613-22. PubMed ID: 19487031
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of p21WAF1 expression is mediated by Sp1/Sp3 transcription factors in TGFbeta1-arrested malignant B cells.
Tvrdík D; Dundr P; Povýsil C; Pytlík R; Planková M
Med Sci Monit; 2006 Jul; 12(7):BR227-34. PubMed ID: 16810128
[TBL] [Abstract][Full Text] [Related]
27. Level of mIa expression on mitogen-stimulated murine B lymphocytes is dependent on position in cell cycle.
Monroe JG; Cambier JC
J Immunol; 1983 Feb; 130(2):626-31. PubMed ID: 6600247
[TBL] [Abstract][Full Text] [Related]
28. The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma.
Schneider EM; Torlakovic E; Stühler A; Diehl V; Tesch H; Giebel B
J Pathol; 2004 Dec; 204(5):538-45. PubMed ID: 15538755
[TBL] [Abstract][Full Text] [Related]
29. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig.
Muraguchi A; Kehrl JH; Butler JL; Fauci AS
J Immunol; 1984 Jan; 132(1):176-80. PubMed ID: 6197443
[TBL] [Abstract][Full Text] [Related]
30. Flow acetone-staining technique: a highly efficient procedure for the simultaneous analysis of DNA content, cell morphology, and immunophenotype by flow cytometry.
Carbonari M; Mancaniello D; Tedesco T; Fiorilli M
Cytometry A; 2008 Feb; 73(2):168-74. PubMed ID: 18189284
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro.
Zhang C; Cui GH; Liu F; Wu QL; Chen Y
Acta Pharmacol Sin; 2006 Nov; 27(11):1438-46. PubMed ID: 17049119
[TBL] [Abstract][Full Text] [Related]
32. Transferrin receptor synthesis is an early event in B cell activation.
Futran J; Kemp JD; Field EH; Vora A; Ashman RF
J Immunol; 1989 Aug; 143(3):787-92. PubMed ID: 2473110
[TBL] [Abstract][Full Text] [Related]
33. Nuclear morphology and morphometry of B-lymphocyte transformation. Implications for follicular center cell lymphomas.
Dardick I; Sinnott NM; Hall R; Bajenko-Carr TA; Setterfield G
Am J Pathol; 1983 Apr; 111(1):35-49. PubMed ID: 6340518
[TBL] [Abstract][Full Text] [Related]
34. Effect of TGF-beta1 on cell cycle regulatory proteins in LPS-stimulated normal mouse B lymphocytes.
Bouchard C; Fridman WH; Sautès C
J Immunol; 1997 Nov; 159(9):4155-64. PubMed ID: 9379008
[TBL] [Abstract][Full Text] [Related]
35. Transgenic expression of CD40L and interleukin-2 induces an autologous antitumor immune response in patients with non-Hodgkin's lymphoma.
Takahashi S; Yotnda P; Rousseau RF; Mei Z; Smith S; Rill D; Younes A; Brenner MK
Cancer Gene Ther; 2001 May; 8(5):378-87. PubMed ID: 11477458
[TBL] [Abstract][Full Text] [Related]
36. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
37. Flow cytometric recognition of clastogen induced chromatin damage in G0/G1 lymphocytes by non-stoichiometric Hoechst fluorochrome binding.
Kubbies M
Cytometry; 1990; 11(3):386-94. PubMed ID: 1692786
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-13 responsiveness and interleukin-13 receptor expression in non-Hodgkin's lymphoma and reactive lymph node B cells. Modulation by CD40 activation.
Billard C; Caput D; Vita N; Ferrara P; Orrico M; Gaulard P; Boumsell L; Bensussan A; Farcet JP
Eur Cytokine Netw; 1997 Mar; 8(1):19-27. PubMed ID: 9110144
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle.
Muraguchi A; Miyazaki K; Kehrl JH; Fauci AS
J Immunol; 1984 Sep; 133(3):1283-7. PubMed ID: 6086754
[TBL] [Abstract][Full Text] [Related]
40. Local lymph node assay: differentiating allergic and irritant responses using flow cytometry.
Gerberick GF; Cruse LW; Ryan CA
Methods; 1999 Sep; 19(1):48-55. PubMed ID: 10525437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
